DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Kwon ED, Drake CG, Scher HI. et al.
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): A multicentre, randomised, double-blind, phase 3 trial.
Lancet Oncol 2014;
15: 700-712
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.